Feb 11 (Reuters) - China has officially charged AstraZeneca's former regional head, Leon Wang, who was detained by authorities in the country more than a year ago in relation to probes into the ...

AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. Now, the Big Pharma has penned a $630 million deal for the remaining rights in ...

PHARMACEUTICAL giant AstraZeneca has announced plans to invest US$15bn in China, deepening its presence in the country’s manufacturing and research ecosystem and citing China’s growing “scientific ...

(Reuters) -AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for ...

AstraZeneca has struck a £13billion deal with a Chinese drug giant, days before shares in the British group start trading on the stock market in New York. Having outlined an £11billion investment ...

Pfizer ended its six-month effort to buy AstraZeneca Monday following the London-based company's May 19 rejection of its last bid of 55 pounds a share in cash and stock. While British takeover law ...

AstraZeneca (AZN) on Thursday announced a $15B investment in China through 2030 to expand medicines manufacturing and R&D. The investment, announced during the UK Prime Minister’s official visit to ...